Search

Issue
Title
Authors
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S.V., Biryukova E.V., Solovievа I.V.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I.Y., Bagriy A.E., Mikhailichenko E.S., Kutya A.E., Sovpel Y.A.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series
Smirnova E.Y.
Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin
Biryukova E.V.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.A.
Screening, diagnosis and treatment of early carbohydrate metabolism disorders
Demidova I.Y., Boeva V.V.
Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection
Zhurtova I.B., Gubachikova A.M., Aramisova L.S., Anaeva L.A., Abdul Moati H.A.
Vildagliptin – 15 years in active service with diabetologists
Pavlova M.G.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V.I., Shatalova O.V., Klykova M.S., Stetsky N.P.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Modern possibilities for assessing glycemia in diabetic patients
Chernikova N.A., Degtyareva E.I.
Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age
Markina J.M.
The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow
Antsiferov M.B., Antsiferova D.M., Koteshkova O.M., Demidov N.A.
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Demidov N.A.
How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary
Astamirova K.S., Gatina A.I., Gorbunova Y.S., Demidov N.A., Ivanenko T.S., Kolesnikova M.I., Lapteva O.A., Morozova I.V., Parshina V.A., Presnyakova O.Y., Smirnova E.Y., Smirnova N.P., Startseva M.A., Khamrazhanov Z.A., Kholmskaya N.I.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A.G., Bagriy A.E., Prikolota A.V., Prikolota O.A., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N.
Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus
Demicheva T.P.
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O.A., Torshin I.Y., Limanova O.A., Grishina T.R., Gromov A.N.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A.E., Shchukina E.V., Efremenko V.A., Mikhailichenko E.S., Suprun E.V.
News of medicine
Kudinova S.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M.B., Zilov A.V., Koteshkova O.M., Demidov N.A.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.S.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.A.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N.A., Knyshenko O.A., Ivanova L.P.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.Y.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V.A., Peterkova V.A.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I.V., Nechaeva G.I., Korennova O.Y., Druk I.V., Nechayeva G.I., Korennova O.Y.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M.B., Demidov N.A., Safronova T.I., Mishra O.A.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S.S., Apetova V.V.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
The place of glyflozins in the management of type 2 diabetes mellitus
Sharonova L.A., Verbovoy A.F.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.V.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A.F., Tsanava I.A., Verbovaya N.I.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M.B., Koteshkova O.M.
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V.I., Nichitenko M.S., Chesnikova A.I.
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N.A., Ametov A.S., Antsiferov M.B.
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N.A., Trukhina L.V., Sinitsyna E.I., Antsiferov M.B.
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A.M., Abdullaeva A.T.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antsiferov M.B.
SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Brashchenkova A.V., Petunina N.A., Brashcenkova A.V.
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A.V., Rudakova A.V.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T.I., Popkova E.N., Trel'skaya N.Y., Emel'yanov V.V., Severina T.I., Popkova Y.N., Trelskaya N.Y., Yemelyanov V.V.
COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Trukhina L.V., Petunina N.A., Truhina L.V.
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR
Antsiferov M.B., Morgunov L.Y., Antsiferov M.B., Morgunov L.Y.
ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS
Morkovskikh N., Morkovskikh N.V.
Advance - movement forward
Petunina N.A., Petunina N.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.A.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I.G., Petryaykina E.E., Koltunov I.E.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.A.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N.A., Antsiferov M.B.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M.B., Petunina N.A., Antsiferov M.B., Petunina N.A.
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M.B., Antciferov M.B.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L.V., Nedosugova L.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A.F., Pashentseva A.V., Verbovaya N.I., Kosareva O.V.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.B.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N.A., Ivanova L.P., Abaeva F.T.
1 - 100 of 177 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies